MLTX Prices $200M Offering
MoonLake Immunotherapeutics announces pricing of upsized $200 million public offering
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
MoonLake Immunotherapeutics announces pricing of upsized $200 million public offering
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.